E-LIB Suche - Ergebnisse für: Julie Westerlin Kjeldsen

1

TCR-engaging scaffolds selectively expand antigen-specific ..:

Tvingsholm, Siri Amanda ; Frej, Marcus Svensson ; Rafa, Vibeke Mindahl...
Journal for ImmunoTherapy of Cancer. 11 (2023) 8 - p. e006847 , 2023

Link: https://doi.org/10.1136/..

2

First in man study: Bcl-Xl_42-CAF®09b vaccines in patients ..:

Mørk, Sofie Kirial ; Kongsted, Per ; Westergaard, Marie Christine Wulff...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

3

Long-term follow-up of anti-PD-1 naïve patients with metast..:

Lorentzen, Cathrine Lund ; Kjeldsen, Julie Westerlin ; Ehrnrooth, Eva..
Journal for ImmunoTherapy of Cancer. 11 (2023) 5 - p. e006755 , 2023

Link: https://doi.org/10.1136/..

4

Arginase-1 targeting peptide vaccine in patients with metas..:

Lorentzen, Cathrine Lund ; Martinenaite, Evelina ; Kjeldsen, Julie Westerlin...
Frontiers in Immunology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

5

Author Correction: A phase 1/2 trial of an immune-modulator..:

Kjeldsen, Julie Westerlin ; Lorentzen, Cathrine Lund ; Martinenaite, Evelina...
Nature Medicine. 28 (2022) 4 - p. 871-871 , 2022

Link: https://doi.org/10.1038/..

6

Therapeutic Cancer Vaccination With a Peptide Derived From ..:

Handlos Grauslund, Jacob ; Holmström, Morten Orebo ; Jørgensen, Nicolai Grønne...
Frontiers in Oncology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

7

Clinical efficacy of T-cell therapy after short-term BRAF-i..:

Borch, Troels Holz ; Harbst, Katja ; Rana, Aynal Haque...
Journal for ImmunoTherapy of Cancer. 9 (2021) 7 - p. e002703 , 2021

Link: https://doi.org/10.1136/..

8

An immunogenic first-in-human immune modulatory vaccine wit..:

Klausen, Uffe ; Grønne Dahlager Jørgensen, Nicolai ; Grauslund, Jacob Handlos...
OncoImmunology. 10 (2021) 1 - p. , 2021

Link: https://doi.org/10.1080/..

9

Adoptive cell therapy with tumor-infiltrating lymphocytes s..:

Kverneland, Anders Handrup ; Chamberlain, Christopher Aled ; Borch, Troels Holz...
Journal for ImmunoTherapy of Cancer. 9 (2021) 10 - p. e003499 , 2021

Link: https://doi.org/10.1136/..

10

A phase 1/2 trial of an immune-modulatory vaccine against I..:

Kjeldsen, Julie Westerlin ; Lorentzen, Cathrine Lund ; Martinenaite, Evelina...
Nature Medicine. 27 (2021) 12 - p. 2212-2223 , 2021

Link: https://doi.org/10.1038/..

11

Tumour-reactive T cell subsets in the microenvironment of o..:

Westergaard, Marie Christine Wulff ; Andersen, Rikke ; Chong, Chloé...
British Journal of Cancer. 120 (2019) 4 - p. 424-434 , 2019

Link: https://doi.org/10.1038/..

12

Correction: Tumour-reactive T cell subsets in the microenvi..:

Westergaard, Marie Christine Wulff ; Andersen, Rikke ; Chong, Chloé...
British Journal of Cancer. 120 (2019) 8 - p. 870-870 , 2019

Link: https://doi.org/10.1038/..

13

Durable Clinical Responses and Long-Term Follow-Up of Stage..:

Kjeldsen, Julie Westerlin ; Iversen, Trine Zeeberg ; Engell-Noerregaard, Lotte...
Frontiers in Immunology. 9 (2018) - p. , 2018

Link: https://doi.org/10.3389/..

14

Reevaluating the Role of High-Density Lipoprotein Cholester..:

Kjeldsen, Emilie Westerlin ; Luo, Jiao ; Nordestgaard, Liv Tybjærg..
Clinical Chemistry. 69 (2023) 12 - p. 1329-1332 , 2023

Link: https://doi.org/10.1093/..

15

HDL cholesterol concentrations and risk of atherosclerotic ..:

Kjeldsen, Emilie Westerlin ; Thomassen, Jesper Qvist ; Frikke-Schmidt, Ruth
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1867 (2022) 1 - p. 159063 , 2022

Link: https://doi.org/10.1016/..